| Name | Title | Contact Details |
|---|
Texas Oncology is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PHM is currently a positive cash flow and profitable company that serves patients with heart disease and other chronic health conditions, and will act as a platform for acquisitions. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively working to identify and evaluate profitable, annuity-based companies to acquire their patient databases and technical expertise at favorable prices. PHM's post acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.
North Carolina Center-rprdctn Med is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Benaroya Research Institute is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.